chr3-98133343-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005338.2(OR5H1):c.646G>A(p.Val216Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,612,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005338.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5H1 | NM_001005338.2 | c.646G>A | p.Val216Ile | missense_variant | 2/2 | ENST00000641874.1 | NP_001005338.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5H1 | ENST00000641874.1 | c.646G>A | p.Val216Ile | missense_variant | 2/2 | NM_001005338.2 | ENSP00000492953.1 | |||
ENSG00000249225 | ENST00000508964.1 | n.94+14698C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000396 AC: 6AN: 151572Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250356Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135356
GnomAD4 exome AF: 0.0000459 AC: 67AN: 1461238Hom.: 0 Cov.: 33 AF XY: 0.0000468 AC XY: 34AN XY: 726900
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151690Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74166
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2023 | The c.646G>A (p.V216I) alteration is located in exon 1 (coding exon 1) of the OR5H1 gene. This alteration results from a G to A substitution at nucleotide position 646, causing the valine (V) at amino acid position 216 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at